The role of tumor-associated macrophages in breast cancer progression (review)

Elias Obeid, Rita Nanda, Yang Xin Fu, Olufunmilayo I. Olopade

Research output: Contribution to journalReview article

86 Citations (Scopus)

Abstract

It is well established that the tumor microenvironment plays a major role in the aggressive behavior of malignant solid tumors. Among cell types associated with tumor microenvironment, tumor-associated macrophages (TAMs) are the most influential for tumor progression. Breast cancer is characterized by having a large population of TAMs, and experimental models have exposed multiple mechanisms by which TAMs interact with and influence the surrounding tumor cells. The process of metastasis involves tumor cells gaining access to the tissue outside the immediate tumor environment and invading the confining extracellular matrix (ECM). Supporting this process, TAMs secrete proangio genic factors such as VEGF to build a network of vessels that provide nutrition for tumor cells, but also function as channels of transport into the ECM. Additionally, TAMs release factors to decrease the local pro-inflammatory antitumor response, suppressing it and providing a means of escape of the tumor cells. Similarly, hypoxia in the tumor microenvironment stimulates macrophages to further produce VEGF and suppress the T-cell immune responses, thus, enhancing the evasion of tumor cells and ultimately metastasis. Given the multiple roles of TAMS in breast cancer progression and metastasis, therapies targeting these cells are in development and demonstrate promising results.

Original languageEnglish (US)
Pages (from-to)5-12
Number of pages8
JournalInternational Journal of Oncology
Volume43
Issue number1
DOIs
StatePublished - Jul 1 2013

Fingerprint

Macrophages
Breast Neoplasms
Neoplasms
Tumor Microenvironment
Neoplasm Metastasis
Vascular Endothelial Growth Factor A
Extracellular Matrix
Tumor Escape
Cell- and Tissue-Based Therapy
Theoretical Models
T-Lymphocytes
Population

Keywords

  • Angiogenesis
  • Breast cancer
  • Extracellular matrix
  • Hypoxia
  • Toll-like receptors
  • Tumor microenvironment
  • Tumor-associated macrophges
  • Vascular endothelial growth factor

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

The role of tumor-associated macrophages in breast cancer progression (review). / Obeid, Elias; Nanda, Rita; Fu, Yang Xin; Olopade, Olufunmilayo I.

In: International Journal of Oncology, Vol. 43, No. 1, 01.07.2013, p. 5-12.

Research output: Contribution to journalReview article

Obeid, Elias ; Nanda, Rita ; Fu, Yang Xin ; Olopade, Olufunmilayo I. / The role of tumor-associated macrophages in breast cancer progression (review). In: International Journal of Oncology. 2013 ; Vol. 43, No. 1. pp. 5-12.
@article{8c128270c1e34aada440c815c287a439,
title = "The role of tumor-associated macrophages in breast cancer progression (review)",
abstract = "It is well established that the tumor microenvironment plays a major role in the aggressive behavior of malignant solid tumors. Among cell types associated with tumor microenvironment, tumor-associated macrophages (TAMs) are the most influential for tumor progression. Breast cancer is characterized by having a large population of TAMs, and experimental models have exposed multiple mechanisms by which TAMs interact with and influence the surrounding tumor cells. The process of metastasis involves tumor cells gaining access to the tissue outside the immediate tumor environment and invading the confining extracellular matrix (ECM). Supporting this process, TAMs secrete proangio genic factors such as VEGF to build a network of vessels that provide nutrition for tumor cells, but also function as channels of transport into the ECM. Additionally, TAMs release factors to decrease the local pro-inflammatory antitumor response, suppressing it and providing a means of escape of the tumor cells. Similarly, hypoxia in the tumor microenvironment stimulates macrophages to further produce VEGF and suppress the T-cell immune responses, thus, enhancing the evasion of tumor cells and ultimately metastasis. Given the multiple roles of TAMS in breast cancer progression and metastasis, therapies targeting these cells are in development and demonstrate promising results.",
keywords = "Angiogenesis, Breast cancer, Extracellular matrix, Hypoxia, Toll-like receptors, Tumor microenvironment, Tumor-associated macrophges, Vascular endothelial growth factor",
author = "Elias Obeid and Rita Nanda and Fu, {Yang Xin} and Olopade, {Olufunmilayo I.}",
year = "2013",
month = "7",
day = "1",
doi = "10.3892/ijo.2013.1938",
language = "English (US)",
volume = "43",
pages = "5--12",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "1",

}

TY - JOUR

T1 - The role of tumor-associated macrophages in breast cancer progression (review)

AU - Obeid, Elias

AU - Nanda, Rita

AU - Fu, Yang Xin

AU - Olopade, Olufunmilayo I.

PY - 2013/7/1

Y1 - 2013/7/1

N2 - It is well established that the tumor microenvironment plays a major role in the aggressive behavior of malignant solid tumors. Among cell types associated with tumor microenvironment, tumor-associated macrophages (TAMs) are the most influential for tumor progression. Breast cancer is characterized by having a large population of TAMs, and experimental models have exposed multiple mechanisms by which TAMs interact with and influence the surrounding tumor cells. The process of metastasis involves tumor cells gaining access to the tissue outside the immediate tumor environment and invading the confining extracellular matrix (ECM). Supporting this process, TAMs secrete proangio genic factors such as VEGF to build a network of vessels that provide nutrition for tumor cells, but also function as channels of transport into the ECM. Additionally, TAMs release factors to decrease the local pro-inflammatory antitumor response, suppressing it and providing a means of escape of the tumor cells. Similarly, hypoxia in the tumor microenvironment stimulates macrophages to further produce VEGF and suppress the T-cell immune responses, thus, enhancing the evasion of tumor cells and ultimately metastasis. Given the multiple roles of TAMS in breast cancer progression and metastasis, therapies targeting these cells are in development and demonstrate promising results.

AB - It is well established that the tumor microenvironment plays a major role in the aggressive behavior of malignant solid tumors. Among cell types associated with tumor microenvironment, tumor-associated macrophages (TAMs) are the most influential for tumor progression. Breast cancer is characterized by having a large population of TAMs, and experimental models have exposed multiple mechanisms by which TAMs interact with and influence the surrounding tumor cells. The process of metastasis involves tumor cells gaining access to the tissue outside the immediate tumor environment and invading the confining extracellular matrix (ECM). Supporting this process, TAMs secrete proangio genic factors such as VEGF to build a network of vessels that provide nutrition for tumor cells, but also function as channels of transport into the ECM. Additionally, TAMs release factors to decrease the local pro-inflammatory antitumor response, suppressing it and providing a means of escape of the tumor cells. Similarly, hypoxia in the tumor microenvironment stimulates macrophages to further produce VEGF and suppress the T-cell immune responses, thus, enhancing the evasion of tumor cells and ultimately metastasis. Given the multiple roles of TAMS in breast cancer progression and metastasis, therapies targeting these cells are in development and demonstrate promising results.

KW - Angiogenesis

KW - Breast cancer

KW - Extracellular matrix

KW - Hypoxia

KW - Toll-like receptors

KW - Tumor microenvironment

KW - Tumor-associated macrophges

KW - Vascular endothelial growth factor

UR - http://www.scopus.com/inward/record.url?scp=84879654727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879654727&partnerID=8YFLogxK

U2 - 10.3892/ijo.2013.1938

DO - 10.3892/ijo.2013.1938

M3 - Review article

VL - 43

SP - 5

EP - 12

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 1

ER -